DADI Stock Overview
Dar Al Dawa Development and Investment Co. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Dar Al Dawa Development and Investment Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | د.أ1.26 |
| 52 Week High | د.أ1.42 |
| 52 Week Low | د.أ1.21 |
| Beta | 0.24 |
| 1 Month Change | 0.80% |
| 3 Month Change | 2.44% |
| 1 Year Change | -7.35% |
| 3 Year Change | 9.57% |
| 5 Year Change | 18.87% |
| Change since IPO | -69.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| DADI | JO Pharmaceuticals | JO Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | 1.0% |
| 1Y | -7.4% | 9.2% | 2.1% |
Return vs Industry: DADI underperformed the JO Pharmaceuticals industry which returned 9.2% over the past year.
Return vs Market: DADI underperformed the JO Market which returned 2.1% over the past year.
Price Volatility
| DADI volatility | |
|---|---|
| DADI Average Weekly Movement | 1.8% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in JO Market | 5.7% |
| 10% least volatile stocks in JO Market | 1.4% |
Stable Share Price: DADI has not had significant price volatility in the past 3 months compared to the JO market.
Volatility Over Time: DADI's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | 1,067 | Khaled Harb | www.dadgroup.com |
Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, produces, markets, and commercializes medicines and wellness consumer products. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, nervous system, gastrointestinal, dermatology, eye-ear preparations, genitourinary system and sex hormones, analgesic, respiratory system, and vitamins and natural products. It serves patients in approximately 40 countries throughout the Middle East, North Africa, and Europe.
Dar Al Dawa Development and Investment Co. Ltd. Fundamentals Summary
| DADI fundamental statistics | |
|---|---|
| Market cap | د.أ44.10m |
| Earnings (TTM) | د.أ3.35m |
| Revenue (TTM) | د.أ77.95m |
13.2x
P/E Ratio0.6x
P/S RatioIs DADI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DADI income statement (TTM) | |
|---|---|
| Revenue | د.أ77.95m |
| Cost of Revenue | د.أ47.13m |
| Gross Profit | د.أ30.83m |
| Other Expenses | د.أ27.48m |
| Earnings | د.أ3.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.096 |
| Gross Margin | 39.54% |
| Net Profit Margin | 4.30% |
| Debt/Equity Ratio | 104.2% |
How did DADI perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield67%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 02:05 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dar Al Dawa Development and Investment Co. Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kais Kriaa | AlphaMena |